Timing and Duration of Interventions in Clinical Trials for Patients With Hospitalized Heart Failure-Reference-Cited by-同舟云学术

Timing and Duration of Interventions in Clinical Trials for Patients With Hospitalized Heart Failure

Published:2013-09 Issue:5 Volume:6 Page:1095-1101
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Marti Catherine N.¹,Fonarow Gregg C.¹,Gheorghiade Mihai¹,Butler Javed¹

Affiliation:

1. From the Division of Cardiology, Emory University, Atlanta, GA (C.N.M., J.B.); Division of Cardiology, University of California, Los Angeles (G.C.F.); and Center of Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL (M.G.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference61 articles.

1. Heart Disease and Stroke Statistics—2010 Update

2. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure

3. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

4. Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart FailureA Randomized Controlled Trial

5. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart FailureThe EVEREST Clinical Status Trials

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial Recovery in the Systemic Context: A Philosophic Shift for the Heart Failure Subspecialty to Optimize Patient Care;Methodist DeBakey Cardiovascular Journal;2024

2. Treatment Strategies of Improving Quality of Care in Patients With Heart Failure;Korean Circulation Journal;2023

3. Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-10-07

4. Comprehensive care for people living with heart failure and chronic obstructive pulmonary disease—Integration of palliative care with disease-specific care: From guidelines to practice;Frontiers in Cardiovascular Medicine;2022-09-27

5. Sacubitril/Valsartan: A New Dawn has Begun! A Revisited Review;Current Cardiology Reviews;2021-08-31